It has been shown that p21 is a possible target of TFAM, as disruption of TFAM in mouse skin fibroblasts and non-small cell lung cancer cells has led to elevated expression of p21 in previous studies [12, 46]. The gene discussed is TFAM; the disease is small cell lung carcinoma.